{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:00:05Z","timestamp":1791658805234,"version":"4.3.4"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize patients who utilize services for migraine in a large integrated health care network, and describe patterns of care and utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Within health care systems, migraine is a common reason for seeking primary and neurology care, but relatively little is documented about who seeks care and the factors that explain variation in utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using electronic health record (EHR) data from Sutter Health primary care (PC) patients who had at least one office visit to a PC clinic between 2013 and 2017. Migraine status was ascertained from diagnosis codes and medication orders. Control status was assigned to those with no evidence of care for any type of headache. We divided the primary care migraine cohort into two groups: those who received all their care for migraine from PC (denoted PC\u2010M) and those who had \u22651 encounter with a neurologist for migraine (denoted N\u2010M). Migraine cases were also designated as having preexisting migraine if they had an encounter with a migraine diagnosis within (\u00b1) 6\u00a0months of their first study period PC visit and, otherwise, designated as first migraine consult. Two levels of contrasts included: patients with migraine and controls; and within the group of patients with migraine, PC\u2010M and N\u2010M groups. Comorbid conditions were determined from EHR encounter diagnosis codes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 94,149 patients with migraine (including 21,525 N\u2010M and 72,624 PC\u2010M) and 1,248,763 controls.\n                      <jats:italic>Comorbidities<\/jats:italic>\n                      : Proportions of psychiatric [29.8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a028,054) vs. 11.8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0147,043)], autoimmune [(4.4% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a04162) vs. 2.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a031,981)], pain [13.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a012,439) vs. 5.8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a072,049)], respiratory [24.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a023,186) vs. 12.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0153,692)], neurologic [2.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a02688) vs. 0.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a011,321)], and cerebrovascular [1.0% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0945) vs. 0.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a07500)] conditions were higher in the migraine group compared to controls, all\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001. Among patients with migraine, the N\u2010M group was similar to the PC\u2010M group in sex, age, ethnicity, and marital status, but were more likely to have preexisting migraine (49.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a010,734) vs. 36.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a026,317),\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001). Proportions of comorbid conditions were higher among the N\u2010M group than the PC\u2010M group {psychiatric [38.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a08291) vs. 27.2% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a019,763)], autoimmune [6.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a01365) vs. 3.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a02797)], pain [19.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a04218) vs. 11.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a08211)], respiratory [30.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a06516) vs. 23.0% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a016,670)], neurologic [6.0% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a01288) vs. 1.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a01400)], cardiovascular [9.7% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a02091) vs. 7.0% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a05076)], and cerebrovascular [2.3% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0500) vs. 0.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0445)], all\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001}.\n                      <jats:italic>Medications<\/jats:italic>\n                      : During the study period, 82.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a077,762) of patients with migraine received \u22651 prescription order for an acute migraine medication [89.4% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a019,250) of N\u2010M vs. 80.6% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a058,512) of PC]. Opioids were prescribed to 52.9% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a049,837) of patients with migraine [63.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a013,669) for N\u2010M and 49.8% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a036,168) for PC\u2010M patients). During the study period, 61.4% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a057,810) of patients received \u22651 prescription for a migraine preventive medication [81.4% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a017,521) of N\u2010M and 55.5% (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a040,289) of PC\u2010M patients]. The most commonly prescribed classes of preventive medications were antidepressants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients with migraine in a large health system, those who were also cared for in neurology were more likely to receive both acute and preventive medication migraine orders than those patients who did not see a neurologist, with triptans and antidepressants the most commonly prescribed classes of acute and preventive pharmacotherapies, respectively. Opioids were prescribed to approximately half of the total sample and more common in the N\u2010M group. Adjusting for demographics, patients with migraine had higher rates of nearly every comorbidity we assessed and were more likely to utilize services compared to those without migraine. Overall, patients with migraine also cared for in neurology practices used more of all health care resource types under consideration and had more medical issues, which may be due in some part to a more severe, frequent and disabling disease state compared to those who sought care exclusively from PC practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.14033","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T10:54:01Z","timestamp":1608807241000},"page":"462-484","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The migraine signature study: Methods and baseline results"],"prefix":"10.1111","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2775-3275","authenticated-orcid":false,"given":"Alice R.","family":"Pressman","sequence":"first","affiliation":[{"name":"Center for Health Systems Research Sutter Health Walnut Creek CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn C.","family":"Buse","sequence":"additional","affiliation":[{"name":"Montefiore Headache Center Albert Einstein College of Medicine Bronx NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Center for Health Systems Research Sutter Health Walnut Creek CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti J.","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Health Systems Research Sutter Health Walnut Creek CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Scott","sequence":"additional","affiliation":[{"name":"Center for Health Systems Research Sutter Health Walnut Creek CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M.","family":"Chia","sequence":"additional","affiliation":[{"name":"Center for Observational Research Amgen Thousand Oaks CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Szekely","sequence":"additional","affiliation":[{"name":"Center for Observational Research Amgen Thousand Oaks CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter F.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Medcurio Inc. Oakland CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Montefiore Headache Center Albert Einstein College of Medicine Bronx NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.073221"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2010.05.011"},{"issue":"538","key":"e_1_2_9_6_1","first-page":"388","article-title":"How do patients referred to neurologists for headache differ from those managed in primary care?","volume":"57","author":"Ridsdale L","year":"2007","journal-title":"Br J Gen Pract"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.7.830"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3802087.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423618000324"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.00988.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.01909.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142044.22226.54"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13407"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415621294"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-014-0129-2"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmp062"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12482"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-251"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12499"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13157"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12074"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(89)90159-5"},{"key":"e_1_2_9_23_1","volume-title":"Five Things Physicians and Patients Should Question","author":"American Headache Society: Choosing W","year":"2013"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.02050.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13588"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01275.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.19030056"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13429"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pny028"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04169.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415590242"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13281"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-1084-y"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-016-0701-2"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020498"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k96"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0964-5"},{"issue":"1","key":"e_1_2_9_38_1","first-page":"S14","article-title":"Comorbidity of migraine","volume":"50","author":"Bi\u00e7akci \u015e","year":"2013","journal-title":"Noro Psikiyatr Ars"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.3.283"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d0cc8b"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3914"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31823b6296"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00631.x"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01703.x"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.02032.x"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2012.02140.x"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414547138"},{"issue":"16","key":"e_1_2_9_48_1","doi-asserted-by":"crossref","first-page":"P1.164","DOI":"10.1212\/WNL.86.16_supplement.P1.164","article-title":"Understanding patient adherence to prophylactic migraine medications","volume":"86","author":"Vanya M","year":"2016","journal-title":"Neurology"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1590\/2176-9451.19.4.027-029.ebo"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.14033","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:51:33Z","timestamp":1762084293000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1111\/head.14033"],"URL":"https:\/\/doi.org\/10.1111\/head.14033","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"2020-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}